Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Asset disposition
Acq. announced
Director departure
|
|
MEI Pharma, Inc. (MEIP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2023 |
4
| Urso David M (President and CEO) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 166,571 options to buy
@ $7.5, valued at
$1.2M
|
|
| 03/01/2023 |
4
| Baltic Charles V. III (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Bought 81,500 shares
@ $0.225, valued at
$18.3k
|
|
| 07/07/2022 |
4
| Baltic Charles V. III (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 87,500 options to buy
@ $0.54, valued at
$47.3k
|
|
| 07/07/2022 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 88 options to buy
@ $0.54, valued at
$47.3 |
|
| 07/07/2022 |
4
| Glover Nicholas (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 87,500 options to buy
@ $0.54, valued at
$47.3k
|
|
| 07/07/2022 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 87,500 options to buy
@ $0.54, valued at
$47.3k
|
|
| 07/07/2022 |
4
| Cohen Cheryl (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 87,500 options to buy
@ $0.54, valued at
$47.3k
|
|
| 07/07/2022 |
4
| GOLD DANIEL P PHD (CEO) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 1,496,000 options to buy
@ $0.54, valued at
$807.8k
|
|
| 07/07/2022 |
4
| Drazba Brian G. (CFO) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 350,000 options to buy
@ $0.54, valued at
$189k
|
|
| 07/07/2022 |
4
| Reynolds Thomas C (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 87,500 options to buy
@ $0.54, valued at
$47.3k
|
|
| 07/07/2022 |
4
| White Christine Anna (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 87,500 options to buy
@ $0.54, valued at
$47.3k
|
|
| 07/07/2022 |
4
| Urso David M (COO & GC) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 1,050,000 options to buy
@ $0.54, valued at
$567k
|
|
| 07/07/2022 |
4
| KANGO SUJAY (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 87,500 options to buy
@ $0.54, valued at
$47.3k
|
|
| 07/07/2022 |
4
| GHALIE RICHARD G (Chief Medical Officer) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Paid exercise price by delivering 8,196 shares
@ $0.54, valued at
$4.4k
Granted 560,000 options to buy
@ $0.54, valued at
$302.4k
|
|
| 11/23/2021 |
4
| KANGO SUJAY (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 58,334 options to buy
@ $2.69, valued at
$156.9k
|
|
| 07/06/2021 |
4
| White Christine Anna (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.95, valued at
$147.5k
|
|
| 07/06/2021 |
4
| Reynolds Thomas C (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.95, valued at
$147.5k
|
|
| 07/06/2021 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.95, valued at
$147.5k
|
|
| 07/06/2021 |
4
| Glover Nicholas (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.95, valued at
$147.5k
|
|
| 07/06/2021 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.95, valued at
$147.5k
|
|
| 07/06/2021 |
4
| Cohen Cheryl (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.95, valued at
$147.5k
|
|
| 07/06/2021 |
4
| Clemens Kevan (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.95, valued at
$147.5k
|
|
| 07/06/2021 |
4
| Baltic Charles V. III (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.95, valued at
$147.5k
|
|
| 07/06/2021 |
4
| GHALIE RICHARD G (Chief Medical Officer) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 320,000 options to buy
@ $2.95, valued at
$944k
|
|
|
|
|